These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 12357871

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Glycosaminoglycans inhibit neurodegenerative effects of serum amyloid P component in vitro.
    Urbányi Z, Forrai E, Sárvári M, Likó I, Illés J, Pázmány T.
    Neurochem Int; 2005 May; 46(6):471-7. PubMed ID: 15769549
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.
    Dedeoglu A, Cormier K, Payton S, Tseitlin KA, Kremsky JN, Lai L, Li X, Moir RD, Tanzi RE, Bush AI, Kowall NW, Rogers JT, Huang X.
    Exp Gerontol; 2004 May; 39(11-12):1641-9. PubMed ID: 15582280
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Games played by rogue proteins in prion disorders and Alzheimer's disease.
    Aguzzi A, Haass C.
    Science; 2003 Oct 31; 302(5646):814-8. PubMed ID: 14593165
    [Abstract] [Full Text] [Related]

  • 37. Novel therapeutic strategies for the treatment of protein-misfolding diseases.
    Rochet JC.
    Expert Rev Mol Med; 2007 Jun 28; 9(17):1-34. PubMed ID: 17597554
    [Abstract] [Full Text] [Related]

  • 38. Amyloidosis and neurodegenerative diseases: current treatments and new pharmacological options.
    Tillement JP, Lecanu L, Papadopoulos V.
    Pharmacology; 2010 Jun 28; 85(1):1-17. PubMed ID: 19923873
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Out, Out--Making Amyloid's Candle Briefer.
    Comenzo RL.
    N Engl J Med; 2015 Sep 17; 373(12):1167-9. PubMed ID: 26376140
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.